Does CRIZOTINIB Cause Activated partial thromboplastin time prolonged? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Activated partial thromboplastin time prolonged have been filed in association with CRIZOTINIB (Xalkori). This represents 0.2% of all adverse event reports for CRIZOTINIB.
15
Reports of Activated partial thromboplastin time prolonged with CRIZOTINIB
0.2%
of all CRIZOTINIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From CRIZOTINIB?
Of the 15 reports, 1 (6.7%) resulted in death, 1 (6.7%) required hospitalization.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRIZOTINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does CRIZOTINIB Cause?
Death (2,028)
Neoplasm progression (1,161)
Nausea (820)
Disease progression (677)
Diarrhoea (631)
Vomiting (600)
Fatigue (419)
Off label use (353)
Dyspnoea (352)
Visual impairment (315)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which CRIZOTINIB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
CRIZOTINIB vs CROFELEMER
CRIZOTINIB vs CROMOLYN
CRIZOTINIB vs CROTALIDAE POLYVALENT IMMUNE FAB
CRIZOTINIB vs CUBICIN
CRIZOTINIB vs CUPRIC